05:18:21 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



01 Communique Laboratory Inc
Symbol ONE
Shares Issued 65,203,807
Close 2013-09-04 C$ 0.225
Market Cap C$ 14,670,857
Recent Sedar Documents

ORIGINAL: 01 Communique Reports Results for Third Quarter Fiscal 2013

2013-09-05 08:13 ET - News Release

01 Communique Reports Results for Third Quarter Fiscal 2013

Canada NewsWire

TORONTO, Sept. 5, 2013 /CNW/ -01 Communique Laboratory Inc. (ONE:TSX) today announced results for its third quarter 2013 which ended July 31, 2013. The loss for the third quarter 2013 was $584,941 compared to $697,693 in 2012 a decrease of $112,852. Excluding non-cash expenses for stock-based compensation and depreciation the adjusted loss for the third quarter 2013 was $235,187 compared to $271,456 in 2012. The Company completed the quarter with $3,566,150 of cash and cash equivalents.

"The cash operating expenses to run our business, excluding the costs associated with intellectual property revenue, were reduced for the third quarter to approximately $400,000," said Andrew Cheung, President and CEO for 01 Communique. "Reducing expenses to this level still allowed us to continue with development of a competitive product offering and continue to vigorously defend our intellectual property rights against LogMeIn Inc. and Citrix Systems Inc. Going forward, we will continue with these two main objectives."

Citrix Litigation Update -
On May 8, 2013 a hearing took place in front of the United States Patent and Trademark Office's ("USPTO") Patent Trial and Appeal Board ("PTAB") in respect of the Citrix Systems Inc. ("Citrix") appeal of the results of the inter partes re-examination of our United States patent number 6,928,479 ("'479 Patent") which Citrix had requested.  We are now waiting for the PTAB to render their written report. We are confident in the merits of our case and believe the PTAB will uphold the validity of the '479 Patent. Previously the jury in the LogMeIn lawsuit upheld the validity of the 479 Patent as did the USPTO patent examiner in the Right of Appeal Notice ("RAN") and the Examiner's Report filed last year as part of the appeal process.

LogMeIn Appeal Update -
We disagree with the jury's finding of non-infringement in the LogMeIn Inc. ("LogMeIn") case and, as previously announced, on June 26, 2013 we filed a notice of appeal with the United States Court of Appeal for the Federal Circuit (Appeal Nos. 2013-1479). LogMeIn has filed a cross appeal, (Case No. 2013-1525) in respect of the Court Order concluding that our patent was valid and enforceable. Their cross appeal has been consolidated with our appeal. As part of the appeal process we filed our Appeal Brief with the Federal Circuit on August 26, 2013. We are confident in the merits of our appeal.

Financial Highlights -

  • Revenue for the third quarter 2013 was $729,860 compared to $582,440 for the same period in 2012, an increase of $147,420 primarily a result of increased revenue from licensing intellectual property. Revenue from intellectual property for the third quarter 2013 was $669,500 (2012 - $500,000).
  • Cash operating expenses which exclude stock-based compensation and depreciation were $965,254 for the third quarter 2013 compared to $857,185 in 2012 an increase of $108,069 primarily a result of an increase in expenses relating to intellectual property revenue.
  • Excluding expenses related to intellectual property revenue of $568,442 (2012 - $425,000), cash operating expenses for the third quarter 2013 were $396,812 compared to 2012 of $432,185 a reduction of $35,373.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release.

About 01 Communique
Established in 1992, 01 Communique Laboratory Inc. (TSX: ONE) offers a suite of remote access services designed for small-medium sized business, mobile professionals and IT service providers. 01's software as a service offerings are deployed on-demand and include functionality enabling on-line meetings, remote computing and IT support. 01's suite of products includes its remote access offering I'm InTouch (www.imintouch.com), its online meeting offering (www.imintouchmeeting.com) and its remote support offering I'm OnCall (www.imoncall.com ) products are protected in the U.S.A. by its patents #6928479 / #6938076 / #8234701 and in  Canada by its patent #2309398 and Japan by its patent #4,875,094. For more information, visit www.01com.com or call (905) 795-888 or (800) 668-2185 (North America only).

Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release.  Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved.  A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk Factors" in the company's Annual Information Form filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the company cannot assure investors that actual results will be consistent with these forward looking statements. These forward-looking statements are made as of the date of this news release, and the company assumes no obligation to update or revise them to reflect new events or circumstances.



             

01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Financial Position
     
  31-Jul-1331-Oct-12
     
Assets    
Current assets:    
    Cash and cash equivalents $    3,566,150 $  4,547,375
    Accounts receivable                                    41,837 282,981
    Prepaid expenses and other assets                                     69,080    35,676
                                 3,677,067 4,866,032
     
Property and equipment                                      17,961         17,261
  $    3,695,028 $  4,883,293
     
Liabilities and Shareholders' Equity    
     
Current liabilities:    
    Accounts payable and accrued liabilities $    1,117,028 $     407,770
    Deferred revenue                                      25,916                                      34,596
                                  1,142,944                                   442,366
     
Shareholders' equity:    
   Share capital                              39,997,277                              39,566,407
   Contributed surplus                                4,384,066                                3,752,710
   Agent options                                   111,780                                   248,400
   Deficit                            (41,941,039)                            (39,126,590)
                                 2,552,084                                4,440,927
  $    3,695,028 $  4,883,293



01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Operations and Comprehensive Income
For the 3 and 9 month periods ended July 31, 2013 and 2012
 
  for the 3 months ending   for the 9 months ending
  31-Jul-1331-Jul-12   31-Jul-1331-Jul-12
Revenue $729,860$582,440   $1,096,299$753,812
Cost of revenue                         -                        38                         -                       261
               729,860             582,402            1,096,299              753,551
           
Expenses (income)          
Selling, general and administrative             530,394             614,430            1,306,409           1,622,145
Patent enforcement & re-examination expenses                568,442             425,000            1,965,542              425,000
Research and development             216,172             244,092               657,864              737,567
Interest                  (207)                (3,327)                (19,067)               (12,221)
           1,314,801          1,280,195            3,910,748           2,772,491
           
Loss for the period and comprehensive loss           (584,941)          (697,793)           (2,814,449)          (2,018,940)
           
Loss per common share          
Basic            $ (0.009)            $  (0.012)              $  (0.043)            $  (0.033)
Diluted            $ (0.009)             $  (0.012)               $  (0.043)            $  (0.033)
           
Weighted average number of common shares          
Basic        65,203,807        60,636,502          65,080,948         60,428,803
Diluted        65,203,807        60,636,502          65,080,948         60,428,803



01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Cash Flows
For the 3 and 9 month periods ended July 31, 2013 and 2012
           
  three months ending     nine months ending  
  31-Jul-1331-Jul-12   31-Jul-1331-Jul-12
Cash provided by (used in):          
           
Operating activities:          
Loss for the period $     (584,941) $      (697,793)   $    (2,814,449) $    (2,018,940)
Adjustments to reconcile the loss
for the period to net cash flows from
         
operating activities:          
Depreciation                   1,754             1,538                    5,657                    7,099
Stock-based compensation               348,000               424,799                 631,356                925,507
Interest income                    (207)                  (3,327)                   (19,067)                 (12,221)
Change in non-cash working capital                   (1,303)                  87,633                908,318               (217,898)
               (236,697)              (187,150)             (1,288,185)            (1,316,453)
Interest income received                    207                 3,327                   19,067                  12,221
               (236,490)             (183,823)             (1,269,118)            (1,304,232)
           
Financing activities:          
Issue of common shares                       -                 275,450                 294,250                 375,450
Investing activities:          
Purchase of capital assets                     (572)                    (665)                    (6,357)                   (1,455)
Increase (decrease) in cash              (237,062)             90,962                (981,225)               (930,237)
           
Cash and cash equivalents, beginning of period                 3,803,212           2,100,218             4,547,375             3,121,417
Cash and cash equivalents, end of period $     3,566,150 $    2,191,180   $    3,566,150 $     2,191,180
           
           
           

 

 

SOURCE: 01 Communique Laboratory Inc.

Contact:

<p> <b>INVESTOR CONTACT:</b><br/> Brian Stringer<br/> Chief Financial Officer<br/> 01 Communique<br/> (905) 795-2888 x204<br/> <a href="mailto:brian.stringer@01com.com">brian.stringer@01com.com</a> </p>

© 2024 Canjex Publishing Ltd. All rights reserved.